AstraZeneca’s COVID-19 vaccine(English)
- ChAdOx1 nCoV-19 vaccine developed at Oxford University and consists of a replication-deficient chimpanzee adenoviral vector ChAdOx1, containing the SARS-CoV-2 structural surface glycoprotein antigen (spike protein; nCoV-19) gene
- COVID-19, STOIC
- Vaccination, Virology
- https://doi.org…6736(20)32661-1